RedShiftBio Microfluidic Modulation Spectroscopy

Next Generation
in Protein
Characterization

RedShiftBio provides a next-generation infrared technology with advanced data analytics to facilitate better, faster decision making in biopharmaceutical development from discovery to market via the direct measurement of previously undetectable change in protein structural attributes critical to drug product efficacy and quality.

Structure

Aggregation

Quantitation

Similarity

stability

Biosimilar Comparison and Accelerated Stability Predictions Based on <2% Secondary Structure Differences Using Microfluidic Modulation Spectroscopy (MMS)

The ability to measure even the smallest structural differences between
engineered biosimilars and their innovator molecules is vital to ensure successful approval and has utility for a wide range of related applications.

Read Our Newest App Note

AQS³®pro

The Next Generation in Protein Characterization

The AQS³pro brings protein secondary structure measurement into every stage of the biopharmaceutical pipeline. The AQS3pro generates repeatable, automated measurements with high sensitivity in complex formulation conditions that are not possible with traditional analytical methods.